Supplementary Materials for:
BRAF Gene Amplification Can Promote Acquired Resistance to MEK
Inhibitors in Cancer Cells Harboring the BRAF V600E Mutation
Ryan B. Corcoran, Dora Dias-Santagata, Kristin Bergethon, A. John Iafrate, Jeffrey
Settleman,* Jeffrey A. Engelman*
*To whom correspondence should be addressed. E-mail: Settleman.jeffrey{at}gene.com (J.S.);
jengelman{at}partners.org (J.A.E.)
This PDF file includes:
- Fig. S1. AR cells are resistant to multiple MEK and BRAF inhibitors.
- Fig. S2. The ability of AZD6244 and AZ628 to inhibit ERK phosphorylation is
attenuated in AR cells.
- Fig. S3. CRAF is not amplified in AR cells.
- Fig. S4. Knockdown of BRAF, but not CRAF, restores the ability of AZD6244 to
inhibit ERK phosphorylation.
- Fig. S5. Resistance caused by overexpression of V600E BRAF can be overcome by
combined MEK and BRAF inhibition.
- Fig. S6. Enhanced inhibition of ERK phosphorylation underlies the increased sensitivity of parental cells to combination treatment with AZD6244 and AZ628.
- Table S1. BRAF amplification in BRAF-mutant human colorectal cancer.
[Download PDF]
Technical Details
Format: Adobe Acrobat PDF
Size: 333 KB
Citation: R. B. Corcoran, D. Dias-Santagata, K. Bergethon, A. J. Iafrate, J.
Settleman, J. A. Engelman, BRAF Gene Amplification Can Promote Acquired Resistance to MEK
Inhibitors in Cancer Cells Harboring the BRAF V600E Mutation.
Sci. Signal. 3, ra84 (2010).
© 2010 American Association for the Advancement of Science